Bronchiolitis obliterans organizing pneumonia (BOOP) is a diffuse infiltrative pulmonary disorder that has an insidious onset. The patient often presents with flulike symptoms and radiological findings showing bilateral patchy infiltrates. Histological features show fibromyxoid connective tissue plugs that are evenly spaced in small distal airways and alveolar spaces. Treatment for BOOP is corticosteroid therapy. Critical care nurses must be cognizant of BOOP as a differential diagnosis for patients for whom antibiotic therapy has not resolved symptoms.
CASE STUDY
Mrs Roman, a 50-year-old, presented to the emergency department with a dry cough, trouble breathing, and shortness of breath especially when performing activities of daily living. A chest radiograph demonstrated patchy pulmonary infiltrates and irregular nodular opacities in both lungs. Consequently, she was admitted to the hospital. Her medical history consisted of obesity and insulindependent diabetes mellitus. On admission to the hospital, Mrs Roman continued to be short of breath, with a respiratory rate of 44 breaths/min and a resting oxygen saturation of 86%. Other vital signs were blood pressure of 156/88 mm Hg, heart rate of 116 beats/min, and temperature of 38.5-C. Crackles were heard bilaterally in both lungs. Supplemental oxygen was administered via facial mask. Laboratory values revealed an erythrocyte sedimentation rate of 78 mm/h, a leukocyte count of 13,550 cells/L, C-reactive protein level of 122 mg/L, and a serum albumin level of 3.0 g/dL. Other than being hyperglycemic, all other laboratory values were normal. Cultures of the blood, sputum, and urine were negative. Pulmonary function tests revealed decreased forced vital capacity, total lung capacity, and single breath diffusing capacity.
Because of the chest radiography findings, a highresolution chest computerized tomography scan was performed, which demonstrated bilateral patchy, ''groundglass'' opacities with a triangular area of consolidation with the base along the pleural surface of the lung posteriorly. A bronchoscopy with a bronchoalveolar lavage was performed, and pneumonia was ruled out. Oral prednisone at 60 mg/d was ordered. Mrs Roman's lung problems continued to worsen, and therefore, on the seventh day of her admission, she had an open surgical lung biopsy via video-assisted thoracoscopy. Tissue samples were taken from 3 different lung sites, which confirmed bronchiolitis obliterans organizing pneumonia (BOOP). Results of the biopsies displayed myxoid fibroblastic tissue, foamy macrophages, and lymphocytes in the alveolar spaces. There was also plugging of the distal bronchioles and alveolar spaces with organized inflammatory exudates. Lung biopsy cultures and stains were negative for organisms. Consequently, she was started on intravenous methylprednisolone 80 mg every 8 hours for 5 days, followed by prednisone 1 mg/ kg. This was gradually tapered and she was discharged 4 weeks after admission on 60 mg of prednisone per day and on home oxygen. Over the next 14 months, the prednisone was gradually decreased and stopped with total resolution of the BOOP as noted on follow-up chest radiography.
Bronchiolitis obliterans organizing pneumonia is an interstitial lung disease that was first described by Epler and associates in 1985. 1, 2 Since that time, BOOP has been reported worldwide 3 as a cause of acute respiratory illness in adults. This article will define BOOP, present epidemiology, pathophysiology, clinical manifestations, differential diagnosis, diagnostic studies, and treatment and illustrate the difficulty in treating patients with BOOP from a nursing perspective.
Bronchiolitis obliterans organizing
pneumonia is an interstitial lung disease that was first described in 1985.
DEFINITION, EPIDEMIOLOGY, AND MORTALITY
The critical care nurse must first understand that bronchiolitis is a term used to describe many inflammatory diseases that affect the bronchioles. 1 Obliterans refers to obliterating or destroying the airways. In 1901, Dr Lange first described submucosal and peribronchiolar fibrosis leading to the obliteration of bronchioles 2,3 ; however, these patients did not have organizing pneumonia. Later, Dr Epler and his colleagues described BOOP as a lung disease characterized by intraluminal and endobronchial plugs of connective tissue composed of fibroblasts and myofibroblasts that fill terminal bronchioles and extend in a continuous fashion into the alveoli, representing an organizing pneumonia. [3] [4] [5] [6] These outline the branches of the inflamed alveolar ducts and distal airways, which leads to restricted lung volumes and decreased vital capacity. Critical care nurses may recognize that the term BOOP is specific for a lesion occurring in the distal bronchioles and alveoli simultaneously.
TYPES AND CAUSES OF BOOP
In many cases, the cause of BOOP cannot be determined. Dr Epler 5 identifies several causes of BOOP and classifies them as idiopathic, postinfective, chemical, and environmental irritants. Recently, the chemical diacetyl 6, 7 has been getting lots of attention in the medical literature as being a chemical irritant from popcorn factories and inhaling the vapors of microwave popcorn that leads to BOOP. Regardless of the cause of BOOP, it leads to a final clinical pathway of inflammation in the bron-chioles and alveolar ducts that may be devastating if the critical care nurse does not detect this promptly.
PATHOPHYSIOLOGY
The key pathophysiologic findings of BOOP are related to an inflammatory pathway leading to alveolar and bronchiolar inflammation, and foamy, lipid-laden macrophages leads to the formation of fibromyxoid connective tissue plugs. 8 These plugs of granulation tissue form polyps that are migratory within the alveolar ducts or may be attached to the wall. 4, 5, 9 The polyps extend in a continuous fashion from the alveoli into the distal bronchioles, representing an organizing pneumonia. 4, 5 
CLINICAL MANIFESTATIONS
The onset of BOOP is usually acute (1 week) to subacute (months) no matter what the causative factor, with a mean time of 4 to 10 weeks. Patients commonly present with weeks to months of nonspecific respiratory symptoms. On physical assessment, in more than 80% of patients with BOOP, the critical care nurse may note tachypnea, hypoxia, and auscultate respiratory crackles over the involved lung fields. 10 Although the clinical manifestations of BOOP vary, typical presentation is flulike symptoms (fever and night sweats, malaise, nonproductive cough and dyspnea, and sore throat), bilateral crackles, and patchy infiltrates noted on the chest radiograph. Bronchiolitis obliterans organizing pneumonia is most common in the fourth to sixth decade of life 3, 11 and represents 20% to 30% of the chronic infiltrative lung diseases. Bronchiolitis obliterans organizing pneumonia occurs equally in men and women, with no corollary relationship with smoking. 3 There is no significant difference noted in the incidence within the United States and that of other countries worldwide. 3 There is also no racial predilection reported. MacLaughlin and King 10 and McKee and Epler 12 note 3% to 13% mortality from BOOP depending on the underlying cause of BOOP.
PROGNOSIS AND INCIDENCE OF RELAPSE
Most patients with BOOP fully recover after a full course of corticosteroids. However, the success of this treatment is dependent on the presence of other comorbidities and associated disorders. 2, 4, 10, 11, 13 Furthermore, relapses occur in approximately one-third to one-half of patients and have been linked to several factors such as completion of the recommended corticosteroid treatment regimen and the severity of hypoxemia upon initial presentation. 5, 12, 14 cellular differential revealing increased neutrophils as high as 72% lymphocytes. 3 MacLaughlin and King 10 indicate that hypoalbuminemia may be present in patients with BOOP. Erythrocyte sedimentation rates are increased to greater than 60 mm/h because of the overwhelming pulmonary inflammatory response. 2, 5, 16 C-reactive protein may also be increased. 2, 15, 16 
DIFFERENTIAL DIAGNOSIS
Both clinically and radiographically BOOP mimics a variety of other pulmonary disorders. Patients presenting clinically with flulike symptoms and a nonproductive cough with mild dyspnea may lead an astute practitioner's mind to consider a host of differential diagnoses. Radiographic assessment may assist the critical care nurse to narrow down the list to a number of possible diseases and disorders, but the definitive confirmation of BOOP is in the histological results. 9, 17 A diagnosis of BOOP should be considered in patients with a suspected infective pulmonary disorder not responding to antibiotic therapy. 9, 17 DIAGNOSTIC STUDIES
Radiographic Studies
Because radiographic findings in patients with BOOP are also consistent with other pulmonary disorders, chest radiographies do not confirm a diagnosis of BOOP. 1 Three main imaging patterns suggest BOOP. The first is that of bilateral patchy, alveolar, and diffuse interstitial infiltrates that are consistently present on chest roentgenogram. 3, 10, 12, 13, 16, 18 The term migratory is used in the BOOP literature and implies the movement of the granulation tissue within distal airways and alveoli. 10, 13, 16 These lesions may spontaneously regress or vanish 11 and are often present peripherally, just beneath the pleural lining, and are thus termed subpleural. On computerized tomography, such opacities are seen as a ground-glass pattern in the peripheral areas. 5, 16, 18, 19 However, pleural effusions and airway hyperinflation are uncharacteristic in BOOP. 2, 4, 5, 10, 13, 17 The second radiographic finding suggesting BOOP is that of multiple areas of consolidation or solitary lesions. 13, 17, 19 The third chest radiography finding, small linear or crescent-shaped densities surrounding the ground-glass attenuation, is seen in approximately in 20% of patients with BOOP. 2, 13, 17, 19 
High-Resolution Computerized Tomography
Hallmark high-resolution chest computerized tomography images reveal a ground-glass pattern in the subpleural and peribronchial areas. 5, 8, 9, 13, 19 This ground-glass appearance is due to alveolar inflammation and the organizing pneumonia in alveolar ducts. 19 As many as 65% of patients with BOOP have peripheral lower lobe con-solidation, which presents in specific pattern similar to that of a triangle with the base along the pleural surface and the tip toward the mediastinum. 3, 8, 10, 16 As many as 65% of patients with BOOP have peripheral lower lobe consolidation, which presents in a specific pattern similar to that of a triangle.
Video-Assisted Thoracoscopy With Open Lung Biopsy
Although evaluating both clinical presentation and radiological findings may lead the practitioner to a probable BOOP diagnosis, the diagnosis is confirmed via histological data. The preferred method for sample gathering and diagnosis is video-assisted thoracoscopy with open lung biopsy (OLB). 3, 5, 9, 10, 17 The utilization of this technique allows for enhanced visualization, complete tissue sampling, and less risk of sample size errors. Because the distal airway and alveolar lesions are migratory, a chest roentgenogram just before performing the OLB is suggested to ensure the most accurate tissue sampling. 13 
Histological Studies
The main pathologic features confirming the diagnosis of BOOP are organized granulation tissue in the distal bronchioles and the organized alveolar exudates, composed of interstitial infiltrates with mononuclear cells (organizing pneumonia). 2, 4, 5, 13, 19 An OLB tissue sample viewed under microscopic examination is the best means for an accurate diagnosis. Several classic histological findings to definitively diagnose BOOP are as follows: (1) Diffuse distal airway inflammation is seen on examination, as are the very characteristic fibromyxoid, polypoid plugs made up of fibroblastic connective tissue. 4, 5, 9, 13, 20 (2) Large interstitial and alveolar infiltrates that contain mononuclear cells and ''foamy'' macrophages. 3, 9, 16, 17, 20 Foamy macrophages are described as lipid laden 17 because the phagocytized materials are of lipoid origins and the debris found inside the macrophage under the microscope gives them an appearance of bubbling foam. (3) Patchy involvement of pulmonary parenchyma with preservation of background lung architecture 2, 4, 5, 13, 20 due to BOOP occurring within the pulmonary tree. Histologic sampling is imperative because corticosteroid use is contraindicated in many of the differential diagnoses. 21 Findings indicate that large numbers of lymphocytes, often between 20% and 40%, are most characteristic of BOOP. Epler 3 believes that lymphocyte counts greater than 25% are suggestive of BOOP.
TREATMENT AND NURSING CONSIDERATIONS
Patients with BOOP are a challenge for the critical care nurse largely because of the critical nature of the disease process. 1 Treatment and nursing considerations include initiating corticosteroid therapy, considering other medications such as macrolides, collaborating with the pulmonologist, and educating the patient and family about the disease process, procedures, treatment, and complications. 1 Anti-infectives are not routinely used as part of the BOOP treatment regimen because BOOP is a noninfective infiltrative lung disease. 5, 9, 18, 20 The mainstay treatment for BOOP is a long-term course of oral prednisone. 2, 9, 13 The recommended dosing of prednisone is 0.75 to 1 mg/kg/d for 3 months, decreasing to 40 mg/d for an additional 3 months, tapering to 20 mg/d or every other day for a total of 1 year. 5, [8] [9] [10] 13, 20 Most patients improve markedly within the initial 48 hours to 1 week of therapy. 1, 2, 9, 13 The critical care nurse must notify the physician if the patient does not improve within this time frame as other diagnostic testing would be indicated. [16] [17] [18] One must remember that treatment for each patient is individualized, so medications and their dosages may vary in certain patients. The critical care nurse must also closely monitor the patient for complications of steroid therapy such as fluid retention, development of concomitant infections, gastrointestinal bleeding, hyperglycemia, depression, personality changes, psychosis, and restlessness. 5 Although the exact mechanism of action is not understood, the successful treatment of clinical and radiographic findings associated with BOOP through the use of corticosteroids has been well documented.
Although corticosteroids are the preferred treatment, other medications may be useful. Macrolides, a class of anti-infectives including clarithromycin, have been shown to resolve BOOP by decreasing the influx of polymorphonuclear cells in the lungs and slow the production of cytokines, which are notorious for promoting the inflammatory cascade. 20 Erythromycin has also been shown to effectively treat this disorder. 4, 5, 13 Cytotoxic drugs such as cyclophosphamide and azathioprine have been used in patients with BOOP whose symptoms and radiographic studies showed minimal improvement with usual corticosteroid treatments. 2, 12, 17 Inhaled triamcinolone has also been used as an adjunct treatment. 5 Decreased pulmonary symptoms and the return of pulmonary function tests to the patients baseline ranges indicate successful drug therapy.
Vigilant pulmonary assessment and hygiene, coupled with close collaboration with the pulmonary department, are necessary to ensure adequate oxygenation and perfusion, which are key to improving outcomes in patients with BOOP. 1 The critical care nurse must assess daily chest radiography after corticosteroid therapy is implemented to note the resolution of these intra-alveolar findings. Furthermore, the critical care nurse must assess pulse oximetry and arterial blood gases and assess for subtle signs of hypoxemia. Both the maintenance of proper oxygen delivery and proper positioning of patients facilitate oxygenation, thus enhancing patient recovery.
In addition, White and Ruth-Sahd 1 suggest that the critical nurse educate both patients and families about diagnostic tests, pulmonary function tests, and the use and potential complications of long-term steroid therapy. Because patients are subjected to procedures such as bronchoscopy with bronchoalveolar lavage, OLB, and high-resolution computerized tomography, the critical care nurse must provide clear information to alleviate anxiety. A large array of corticosteroid adverse effects may occur because patients with BOOP are often treated for long periods of time. For this reason, extensive medication teaching must be done. For patients with BOOP, excellence in both the art and skill of critical care nursing is imperative to ensure the best possible outcomes. White and Ruth-Sahd 1 suggest potential nursing diagnoses 22 to include the following:
& Impaired gas exchange related to alveolar and bronchiolar inflammation secondary to BOOP & Ineffective airway clearance related to inflammation, edema, and presence of mucus plugs in bronchioles & Ineffective breathing pattern related to hyperventilation secondary to BOOP & Ineffective tissue perfusion: cardiopulmonary related to impaired transport of oxygen & Imbalanced nutrition: less than body requirements related to increased caloric needs secondary to increased work of breathing & Anxiety related to change in health status secondary to BOOP & Activity intolerance related to imbalance between oxygen supply and demand secondary to BOOP & Ineffective health maintenance related to deficient knowledge regarding self-care and treatment of disease For patients with BOOP, excellence in both the art and skill of critical care nursing is imperative to ensure the best possible outcomes.
CONCLUSION
Bronchiolitis obliterans organizing pneumonia is an inflammation that may affect a small region of the lung or the entire lung. Critical care nurses must consider BOOP if a patient with suspected pneumonia and respiratory failure does not respond to standard antibiotic therapy. Critical care nurses positively affect patient outcomes by seeking early diagnosis, instituting prompt treatment with steroids, and providing high-quality comprehensive care. These interventions are essential in reducing complications and mortality as well as attaining better patient outcomes and a high quality of life.
